nodes	percent_of_prediction	percent_of_DWPC	metapath
Mycophenolate mofetil—psoriasis—psoriatic arthritis	0.626	1	CtDrD
Mycophenolate mofetil—ALB—Auranofin—psoriatic arthritis	0.0497	0.188	CbGbCtD
Mycophenolate mofetil—SLCO1B3—Methotrexate—psoriatic arthritis	0.0249	0.094	CbGbCtD
Mycophenolate mofetil—ABCC2—Dexamethasone—psoriatic arthritis	0.0158	0.0599	CbGbCtD
Mycophenolate mofetil—ALB—Prednisone—psoriatic arthritis	0.0158	0.0598	CbGbCtD
Mycophenolate mofetil—SLCO1B1—Methotrexate—psoriatic arthritis	0.0145	0.0547	CbGbCtD
Mycophenolate mofetil—ABCG2—Dexamethasone—psoriatic arthritis	0.0143	0.0541	CbGbCtD
Mycophenolate mofetil—ABCB1—Methylprednisolone—psoriatic arthritis	0.0137	0.0516	CbGbCtD
Mycophenolate mofetil—ABCC2—Methotrexate—psoriatic arthritis	0.0127	0.0481	CbGbCtD
Mycophenolate mofetil—ABCG2—Methotrexate—psoriatic arthritis	0.0115	0.0435	CbGbCtD
Mycophenolate mofetil—ABCB1—Betamethasone—psoriatic arthritis	0.00888	0.0335	CbGbCtD
Mycophenolate mofetil—ABCB1—Prednisolone—psoriatic arthritis	0.00876	0.0331	CbGbCtD
Mycophenolate mofetil—ABCB1—Prednisone—psoriatic arthritis	0.00828	0.0313	CbGbCtD
Mycophenolate mofetil—CYP3A4—Methylprednisolone—psoriatic arthritis	0.00818	0.0309	CbGbCtD
Mycophenolate mofetil—CYP3A5—Dexamethasone—psoriatic arthritis	0.00794	0.03	CbGbCtD
Mycophenolate mofetil—ALB—Methotrexate—psoriatic arthritis	0.00794	0.03	CbGbCtD
Mycophenolate mofetil—CYP2C8—Dexamethasone—psoriatic arthritis	0.00763	0.0288	CbGbCtD
Mycophenolate mofetil—CYP3A4—Triamcinolone—psoriatic arthritis	0.0062	0.0234	CbGbCtD
Mycophenolate mofetil—CYP3A4—Betamethasone—psoriatic arthritis	0.00532	0.0201	CbGbCtD
Mycophenolate mofetil—CYP3A4—Prednisolone—psoriatic arthritis	0.00525	0.0198	CbGbCtD
Mycophenolate mofetil—ABCB1—Dexamethasone—psoriatic arthritis	0.00517	0.0195	CbGbCtD
Mycophenolate mofetil—CYP3A4—Prednisone—psoriatic arthritis	0.00496	0.0187	CbGbCtD
Mycophenolate mofetil—ABCB1—Methotrexate—psoriatic arthritis	0.00415	0.0157	CbGbCtD
Mycophenolate mofetil—CYP3A4—Dexamethasone—psoriatic arthritis	0.0031	0.0117	CbGbCtD
Mycophenolate mofetil—Syncope—Betamethasone—psoriatic arthritis	5.62e-05	0.000514	CcSEcCtD
Mycophenolate mofetil—Arrhythmia—Prednisone—psoriatic arthritis	5.6e-05	0.000512	CcSEcCtD
Mycophenolate mofetil—Infection—Triamcinolone—psoriatic arthritis	5.6e-05	0.000512	CcSEcCtD
Mycophenolate mofetil—Sweating—Methotrexate—psoriatic arthritis	5.6e-05	0.000512	CcSEcCtD
Mycophenolate mofetil—Infection—Methylprednisolone—psoriatic arthritis	5.59e-05	0.000511	CcSEcCtD
Mycophenolate mofetil—Haematuria—Methotrexate—psoriatic arthritis	5.57e-05	0.000509	CcSEcCtD
Mycophenolate mofetil—Shock—Triamcinolone—psoriatic arthritis	5.55e-05	0.000507	CcSEcCtD
Mycophenolate mofetil—Insomnia—Prednisolone—psoriatic arthritis	5.55e-05	0.000507	CcSEcCtD
Mycophenolate mofetil—Alopecia—Prednisone—psoriatic arthritis	5.54e-05	0.000507	CcSEcCtD
Mycophenolate mofetil—Shock—Methylprednisolone—psoriatic arthritis	5.54e-05	0.000506	CcSEcCtD
Mycophenolate mofetil—Hepatobiliary disease—Methotrexate—psoriatic arthritis	5.52e-05	0.000505	CcSEcCtD
Mycophenolate mofetil—Nervous system disorder—Methylprednisolone—psoriatic arthritis	5.52e-05	0.000505	CcSEcCtD
Mycophenolate mofetil—Loss of consciousness—Betamethasone—psoriatic arthritis	5.51e-05	0.000504	CcSEcCtD
Mycophenolate mofetil—Loss of consciousness—Dexamethasone—psoriatic arthritis	5.51e-05	0.000504	CcSEcCtD
Mycophenolate mofetil—Epistaxis—Methotrexate—psoriatic arthritis	5.51e-05	0.000504	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Prednisolone—psoriatic arthritis	5.51e-05	0.000504	CcSEcCtD
Mycophenolate mofetil—Tachycardia—Triamcinolone—psoriatic arthritis	5.51e-05	0.000503	CcSEcCtD
Mycophenolate mofetil—Mental disorder—Prednisone—psoriatic arthritis	5.5e-05	0.000503	CcSEcCtD
Mycophenolate mofetil—Tachycardia—Methylprednisolone—psoriatic arthritis	5.49e-05	0.000502	CcSEcCtD
Mycophenolate mofetil—Skin disorder—Methylprednisolone—psoriatic arthritis	5.47e-05	0.0005	CcSEcCtD
Mycophenolate mofetil—Malnutrition—Prednisone—psoriatic arthritis	5.46e-05	0.000499	CcSEcCtD
Mycophenolate mofetil—Hyperhidrosis—Triamcinolone—psoriatic arthritis	5.45e-05	0.000499	CcSEcCtD
Mycophenolate mofetil—Agranulocytosis—Methotrexate—psoriatic arthritis	5.45e-05	0.000498	CcSEcCtD
Mycophenolate mofetil—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	5.44e-05	0.000497	CcSEcCtD
Mycophenolate mofetil—Convulsion—Dexamethasone—psoriatic arthritis	5.43e-05	0.000497	CcSEcCtD
Mycophenolate mofetil—Convulsion—Betamethasone—psoriatic arthritis	5.43e-05	0.000497	CcSEcCtD
Mycophenolate mofetil—Hypertension—Dexamethasone—psoriatic arthritis	5.41e-05	0.000495	CcSEcCtD
Mycophenolate mofetil—Hypertension—Betamethasone—psoriatic arthritis	5.41e-05	0.000495	CcSEcCtD
Mycophenolate mofetil—Myalgia—Dexamethasone—psoriatic arthritis	5.34e-05	0.000488	CcSEcCtD
Mycophenolate mofetil—Myalgia—Betamethasone—psoriatic arthritis	5.34e-05	0.000488	CcSEcCtD
Mycophenolate mofetil—Anxiety—Dexamethasone—psoriatic arthritis	5.32e-05	0.000486	CcSEcCtD
Mycophenolate mofetil—Anxiety—Betamethasone—psoriatic arthritis	5.32e-05	0.000486	CcSEcCtD
Mycophenolate mofetil—Discomfort—Dexamethasone—psoriatic arthritis	5.28e-05	0.000482	CcSEcCtD
Mycophenolate mofetil—Discomfort—Betamethasone—psoriatic arthritis	5.28e-05	0.000482	CcSEcCtD
Mycophenolate mofetil—Haemoglobin—Methotrexate—psoriatic arthritis	5.27e-05	0.000482	CcSEcCtD
Mycophenolate mofetil—Hypotension—Methylprednisolone—psoriatic arthritis	5.26e-05	0.000481	CcSEcCtD
Mycophenolate mofetil—Pain—Prednisolone—psoriatic arthritis	5.25e-05	0.00048	CcSEcCtD
Mycophenolate mofetil—Haemorrhage—Methotrexate—psoriatic arthritis	5.24e-05	0.000479	CcSEcCtD
Mycophenolate mofetil—Hepatitis—Methotrexate—psoriatic arthritis	5.24e-05	0.000479	CcSEcCtD
Mycophenolate mofetil—Pharyngitis—Methotrexate—psoriatic arthritis	5.2e-05	0.000476	CcSEcCtD
Mycophenolate mofetil—Urinary tract disorder—Methotrexate—psoriatic arthritis	5.18e-05	0.000473	CcSEcCtD
Mycophenolate mofetil—Urethral disorder—Methotrexate—psoriatic arthritis	5.14e-05	0.00047	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	5.14e-05	0.00047	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	5.13e-05	0.000469	CcSEcCtD
Mycophenolate mofetil—Anaphylactic shock—Betamethasone—psoriatic arthritis	5.12e-05	0.000468	CcSEcCtD
Mycophenolate mofetil—Oedema—Dexamethasone—psoriatic arthritis	5.12e-05	0.000468	CcSEcCtD
Mycophenolate mofetil—Oedema—Betamethasone—psoriatic arthritis	5.12e-05	0.000468	CcSEcCtD
Mycophenolate mofetil—Anaphylactic shock—Dexamethasone—psoriatic arthritis	5.12e-05	0.000468	CcSEcCtD
Mycophenolate mofetil—Insomnia—Triamcinolone—psoriatic arthritis	5.1e-05	0.000466	CcSEcCtD
Mycophenolate mofetil—Insomnia—Methylprednisolone—psoriatic arthritis	5.09e-05	0.000465	CcSEcCtD
Mycophenolate mofetil—Infection—Dexamethasone—psoriatic arthritis	5.08e-05	0.000465	CcSEcCtD
Mycophenolate mofetil—Infection—Betamethasone—psoriatic arthritis	5.08e-05	0.000465	CcSEcCtD
Mycophenolate mofetil—Ill-defined disorder—Prednisone—psoriatic arthritis	5.07e-05	0.000463	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Triamcinolone—psoriatic arthritis	5.07e-05	0.000463	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Prednisolone—psoriatic arthritis	5.05e-05	0.000462	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Methylprednisolone—psoriatic arthritis	5.05e-05	0.000462	CcSEcCtD
Mycophenolate mofetil—Visual impairment—Methotrexate—psoriatic arthritis	5.05e-05	0.000462	CcSEcCtD
Mycophenolate mofetil—Anaemia—Prednisone—psoriatic arthritis	5.05e-05	0.000462	CcSEcCtD
Mycophenolate mofetil—Shock—Dexamethasone—psoriatic arthritis	5.04e-05	0.00046	CcSEcCtD
Mycophenolate mofetil—Shock—Betamethasone—psoriatic arthritis	5.04e-05	0.00046	CcSEcCtD
Mycophenolate mofetil—Dyspnoea—Triamcinolone—psoriatic arthritis	5.03e-05	0.00046	CcSEcCtD
Mycophenolate mofetil—Nervous system disorder—Betamethasone—psoriatic arthritis	5.02e-05	0.000459	CcSEcCtD
Mycophenolate mofetil—Nervous system disorder—Dexamethasone—psoriatic arthritis	5.02e-05	0.000459	CcSEcCtD
Mycophenolate mofetil—Agitation—Prednisone—psoriatic arthritis	5.02e-05	0.000459	CcSEcCtD
Mycophenolate mofetil—Thrombocytopenia—Dexamethasone—psoriatic arthritis	5.01e-05	0.000458	CcSEcCtD
Mycophenolate mofetil—Thrombocytopenia—Betamethasone—psoriatic arthritis	5.01e-05	0.000458	CcSEcCtD
Mycophenolate mofetil—Tachycardia—Dexamethasone—psoriatic arthritis	5e-05	0.000457	CcSEcCtD
Mycophenolate mofetil—Tachycardia—Betamethasone—psoriatic arthritis	5e-05	0.000457	CcSEcCtD
Mycophenolate mofetil—Angioedema—Prednisone—psoriatic arthritis	4.99e-05	0.000456	CcSEcCtD
Mycophenolate mofetil—Dyspepsia—Triamcinolone—psoriatic arthritis	4.97e-05	0.000454	CcSEcCtD
Mycophenolate mofetil—Dyspepsia—Methylprednisolone—psoriatic arthritis	4.95e-05	0.000453	CcSEcCtD
Mycophenolate mofetil—Hyperhidrosis—Dexamethasone—psoriatic arthritis	4.95e-05	0.000452	CcSEcCtD
Mycophenolate mofetil—Hyperhidrosis—Betamethasone—psoriatic arthritis	4.95e-05	0.000452	CcSEcCtD
Mycophenolate mofetil—Malaise—Prednisone—psoriatic arthritis	4.93e-05	0.00045	CcSEcCtD
Mycophenolate mofetil—Vertigo—Prednisone—psoriatic arthritis	4.91e-05	0.000449	CcSEcCtD
Mycophenolate mofetil—Eye disorder—Methotrexate—psoriatic arthritis	4.9e-05	0.000448	CcSEcCtD
Mycophenolate mofetil—Syncope—Prednisone—psoriatic arthritis	4.9e-05	0.000448	CcSEcCtD
Mycophenolate mofetil—Tinnitus—Methotrexate—psoriatic arthritis	4.89e-05	0.000447	CcSEcCtD
Mycophenolate mofetil—Anorexia—Dexamethasone—psoriatic arthritis	4.88e-05	0.000446	CcSEcCtD
Mycophenolate mofetil—Anorexia—Betamethasone—psoriatic arthritis	4.88e-05	0.000446	CcSEcCtD
Mycophenolate mofetil—Urticaria—Prednisolone—psoriatic arthritis	4.87e-05	0.000446	CcSEcCtD
Mycophenolate mofetil—Cardiac disorder—Methotrexate—psoriatic arthritis	4.87e-05	0.000445	CcSEcCtD
Mycophenolate mofetil—Pain—Triamcinolone—psoriatic arthritis	4.82e-05	0.000441	CcSEcCtD
Mycophenolate mofetil—Loss of consciousness—Prednisone—psoriatic arthritis	4.8e-05	0.000439	CcSEcCtD
Mycophenolate mofetil—Hypotension—Betamethasone—psoriatic arthritis	4.78e-05	0.000437	CcSEcCtD
Mycophenolate mofetil—Hypotension—Dexamethasone—psoriatic arthritis	4.78e-05	0.000437	CcSEcCtD
Mycophenolate mofetil—Angiopathy—Methotrexate—psoriatic arthritis	4.76e-05	0.000435	CcSEcCtD
Mycophenolate mofetil—Convulsion—Prednisone—psoriatic arthritis	4.73e-05	0.000433	CcSEcCtD
Mycophenolate mofetil—Mediastinal disorder—Methotrexate—psoriatic arthritis	4.73e-05	0.000432	CcSEcCtD
Mycophenolate mofetil—Hypertension—Prednisone—psoriatic arthritis	4.72e-05	0.000431	CcSEcCtD
Mycophenolate mofetil—Chills—Methotrexate—psoriatic arthritis	4.7e-05	0.00043	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	4.66e-05	0.000426	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	4.66e-05	0.000426	CcSEcCtD
Mycophenolate mofetil—Arthralgia—Prednisone—psoriatic arthritis	4.65e-05	0.000425	CcSEcCtD
Mycophenolate mofetil—Myalgia—Prednisone—psoriatic arthritis	4.65e-05	0.000425	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Triamcinolone—psoriatic arthritis	4.65e-05	0.000425	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Methylprednisolone—psoriatic arthritis	4.64e-05	0.000424	CcSEcCtD
Mycophenolate mofetil—Anxiety—Prednisone—psoriatic arthritis	4.63e-05	0.000424	CcSEcCtD
Mycophenolate mofetil—Alopecia—Methotrexate—psoriatic arthritis	4.63e-05	0.000424	CcSEcCtD
Mycophenolate mofetil—Insomnia—Dexamethasone—psoriatic arthritis	4.63e-05	0.000423	CcSEcCtD
Mycophenolate mofetil—Insomnia—Betamethasone—psoriatic arthritis	4.63e-05	0.000423	CcSEcCtD
Mycophenolate mofetil—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	4.62e-05	0.000422	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	4.6e-05	0.000421	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Dexamethasone—psoriatic arthritis	4.6e-05	0.00042	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Betamethasone—psoriatic arthritis	4.6e-05	0.00042	CcSEcCtD
Mycophenolate mofetil—Discomfort—Prednisone—psoriatic arthritis	4.59e-05	0.00042	CcSEcCtD
Mycophenolate mofetil—Mental disorder—Methotrexate—psoriatic arthritis	4.59e-05	0.00042	CcSEcCtD
Mycophenolate mofetil—Malnutrition—Methotrexate—psoriatic arthritis	4.56e-05	0.000417	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Prednisolone—psoriatic arthritis	4.52e-05	0.000413	CcSEcCtD
Mycophenolate mofetil—Dyspepsia—Dexamethasone—psoriatic arthritis	4.51e-05	0.000412	CcSEcCtD
Mycophenolate mofetil—Dyspepsia—Betamethasone—psoriatic arthritis	4.51e-05	0.000412	CcSEcCtD
Mycophenolate mofetil—Urticaria—Triamcinolone—psoriatic arthritis	4.48e-05	0.00041	CcSEcCtD
Mycophenolate mofetil—Urticaria—Methylprednisolone—psoriatic arthritis	4.47e-05	0.000409	CcSEcCtD
Mycophenolate mofetil—Dysgeusia—Methotrexate—psoriatic arthritis	4.47e-05	0.000409	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Triamcinolone—psoriatic arthritis	4.46e-05	0.000408	CcSEcCtD
Mycophenolate mofetil—Anaphylactic shock—Prednisone—psoriatic arthritis	4.46e-05	0.000408	CcSEcCtD
Mycophenolate mofetil—Oedema—Prednisone—psoriatic arthritis	4.46e-05	0.000408	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Methylprednisolone—psoriatic arthritis	4.45e-05	0.000407	CcSEcCtD
Mycophenolate mofetil—Decreased appetite—Betamethasone—psoriatic arthritis	4.45e-05	0.000407	CcSEcCtD
Mycophenolate mofetil—Decreased appetite—Dexamethasone—psoriatic arthritis	4.45e-05	0.000407	CcSEcCtD
Mycophenolate mofetil—Infection—Prednisone—psoriatic arthritis	4.43e-05	0.000405	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	4.42e-05	0.000404	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	4.42e-05	0.000404	CcSEcCtD
Mycophenolate mofetil—Back pain—Methotrexate—psoriatic arthritis	4.42e-05	0.000404	CcSEcCtD
Mycophenolate mofetil—Shock—Prednisone—psoriatic arthritis	4.39e-05	0.000401	CcSEcCtD
Mycophenolate mofetil—Pain—Dexamethasone—psoriatic arthritis	4.38e-05	0.0004	CcSEcCtD
Mycophenolate mofetil—Pain—Betamethasone—psoriatic arthritis	4.38e-05	0.0004	CcSEcCtD
Mycophenolate mofetil—Nervous system disorder—Prednisone—psoriatic arthritis	4.37e-05	0.0004	CcSEcCtD
Mycophenolate mofetil—Tachycardia—Prednisone—psoriatic arthritis	4.35e-05	0.000398	CcSEcCtD
Mycophenolate mofetil—Skin disorder—Prednisone—psoriatic arthritis	4.33e-05	0.000396	CcSEcCtD
Mycophenolate mofetil—Hyperhidrosis—Prednisone—psoriatic arthritis	4.31e-05	0.000394	CcSEcCtD
Mycophenolate mofetil—Anorexia—Prednisone—psoriatic arthritis	4.25e-05	0.000388	CcSEcCtD
Mycophenolate mofetil—Ill-defined disorder—Methotrexate—psoriatic arthritis	4.24e-05	0.000387	CcSEcCtD
Mycophenolate mofetil—Anaemia—Methotrexate—psoriatic arthritis	4.22e-05	0.000386	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Dexamethasone—psoriatic arthritis	4.22e-05	0.000386	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Betamethasone—psoriatic arthritis	4.22e-05	0.000386	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	4.19e-05	0.000383	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Betamethasone—psoriatic arthritis	4.19e-05	0.000383	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Triamcinolone—psoriatic arthritis	4.16e-05	0.00038	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Methylprednisolone—psoriatic arthritis	4.15e-05	0.000379	CcSEcCtD
Mycophenolate mofetil—Malaise—Methotrexate—psoriatic arthritis	4.12e-05	0.000376	CcSEcCtD
Mycophenolate mofetil—Vertigo—Methotrexate—psoriatic arthritis	4.1e-05	0.000375	CcSEcCtD
Mycophenolate mofetil—Leukopenia—Methotrexate—psoriatic arthritis	4.09e-05	0.000374	CcSEcCtD
Mycophenolate mofetil—Urticaria—Betamethasone—psoriatic arthritis	4.07e-05	0.000372	CcSEcCtD
Mycophenolate mofetil—Urticaria—Dexamethasone—psoriatic arthritis	4.07e-05	0.000372	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	4.06e-05	0.000371	CcSEcCtD
Mycophenolate mofetil—Dizziness—Prednisolone—psoriatic arthritis	4.06e-05	0.000371	CcSEcCtD
Mycophenolate mofetil—Asthenia—Triamcinolone—psoriatic arthritis	4.05e-05	0.00037	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Betamethasone—psoriatic arthritis	4.05e-05	0.00037	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Dexamethasone—psoriatic arthritis	4.05e-05	0.00037	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Betamethasone—psoriatic arthritis	4.05e-05	0.00037	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Dexamethasone—psoriatic arthritis	4.05e-05	0.00037	CcSEcCtD
Mycophenolate mofetil—Asthenia—Methylprednisolone—psoriatic arthritis	4.04e-05	0.000369	CcSEcCtD
Mycophenolate mofetil—Insomnia—Prednisone—psoriatic arthritis	4.03e-05	0.000369	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Prednisone—psoriatic arthritis	4e-05	0.000366	CcSEcCtD
Mycophenolate mofetil—Pruritus—Triamcinolone—psoriatic arthritis	3.99e-05	0.000365	CcSEcCtD
Mycophenolate mofetil—Cough—Methotrexate—psoriatic arthritis	3.98e-05	0.000364	CcSEcCtD
Mycophenolate mofetil—Pruritus—Methylprednisolone—psoriatic arthritis	3.98e-05	0.000364	CcSEcCtD
Mycophenolate mofetil—Convulsion—Methotrexate—psoriatic arthritis	3.95e-05	0.000362	CcSEcCtD
Mycophenolate mofetil—Dyspepsia—Prednisone—psoriatic arthritis	3.92e-05	0.000359	CcSEcCtD
Mycophenolate mofetil—Myalgia—Methotrexate—psoriatic arthritis	3.89e-05	0.000355	CcSEcCtD
Mycophenolate mofetil—Chest pain—Methotrexate—psoriatic arthritis	3.89e-05	0.000355	CcSEcCtD
Mycophenolate mofetil—Arthralgia—Methotrexate—psoriatic arthritis	3.89e-05	0.000355	CcSEcCtD
Mycophenolate mofetil—Decreased appetite—Prednisone—psoriatic arthritis	3.87e-05	0.000354	CcSEcCtD
Mycophenolate mofetil—Rash—Prednisolone—psoriatic arthritis	3.87e-05	0.000354	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Prednisolone—psoriatic arthritis	3.86e-05	0.000353	CcSEcCtD
Mycophenolate mofetil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	3.86e-05	0.000353	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Methylprednisolone—psoriatic arthritis	3.85e-05	0.000352	CcSEcCtD
Mycophenolate mofetil—Headache—Prednisolone—psoriatic arthritis	3.84e-05	0.000351	CcSEcCtD
Mycophenolate mofetil—Discomfort—Methotrexate—psoriatic arthritis	3.84e-05	0.000351	CcSEcCtD
Mycophenolate mofetil—Constipation—Prednisone—psoriatic arthritis	3.81e-05	0.000348	CcSEcCtD
Mycophenolate mofetil—Confusional state—Methotrexate—psoriatic arthritis	3.76e-05	0.000343	CcSEcCtD
Mycophenolate mofetil—Dizziness—Triamcinolone—psoriatic arthritis	3.73e-05	0.000341	CcSEcCtD
Mycophenolate mofetil—Anaphylactic shock—Methotrexate—psoriatic arthritis	3.73e-05	0.000341	CcSEcCtD
Mycophenolate mofetil—Dizziness—Methylprednisolone—psoriatic arthritis	3.72e-05	0.00034	CcSEcCtD
Mycophenolate mofetil—Infection—Methotrexate—psoriatic arthritis	3.7e-05	0.000338	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Prednisone—psoriatic arthritis	3.67e-05	0.000336	CcSEcCtD
Mycophenolate mofetil—Asthenia—Dexamethasone—psoriatic arthritis	3.67e-05	0.000336	CcSEcCtD
Mycophenolate mofetil—Asthenia—Betamethasone—psoriatic arthritis	3.67e-05	0.000336	CcSEcCtD
Mycophenolate mofetil—Nervous system disorder—Methotrexate—psoriatic arthritis	3.65e-05	0.000334	CcSEcCtD
Mycophenolate mofetil—Thrombocytopenia—Methotrexate—psoriatic arthritis	3.65e-05	0.000333	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Prednisone—psoriatic arthritis	3.64e-05	0.000333	CcSEcCtD
Mycophenolate mofetil—Nausea—Prednisolone—psoriatic arthritis	3.64e-05	0.000333	CcSEcCtD
Mycophenolate mofetil—Pruritus—Dexamethasone—psoriatic arthritis	3.62e-05	0.000331	CcSEcCtD
Mycophenolate mofetil—Pruritus—Betamethasone—psoriatic arthritis	3.62e-05	0.000331	CcSEcCtD
Mycophenolate mofetil—Skin disorder—Methotrexate—psoriatic arthritis	3.62e-05	0.000331	CcSEcCtD
Mycophenolate mofetil—Hyperhidrosis—Methotrexate—psoriatic arthritis	3.6e-05	0.000329	CcSEcCtD
Mycophenolate mofetil—Vomiting—Triamcinolone—psoriatic arthritis	3.59e-05	0.000328	CcSEcCtD
Mycophenolate mofetil—Vomiting—Methylprednisolone—psoriatic arthritis	3.58e-05	0.000327	CcSEcCtD
Mycophenolate mofetil—Rash—Triamcinolone—psoriatic arthritis	3.56e-05	0.000325	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Triamcinolone—psoriatic arthritis	3.55e-05	0.000325	CcSEcCtD
Mycophenolate mofetil—Anorexia—Methotrexate—psoriatic arthritis	3.55e-05	0.000325	CcSEcCtD
Mycophenolate mofetil—Rash—Methylprednisolone—psoriatic arthritis	3.55e-05	0.000324	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Methylprednisolone—psoriatic arthritis	3.55e-05	0.000324	CcSEcCtD
Mycophenolate mofetil—Urticaria—Prednisone—psoriatic arthritis	3.54e-05	0.000324	CcSEcCtD
Mycophenolate mofetil—Headache—Triamcinolone—psoriatic arthritis	3.53e-05	0.000323	CcSEcCtD
Mycophenolate mofetil—Headache—Methylprednisolone—psoriatic arthritis	3.53e-05	0.000322	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Prednisone—psoriatic arthritis	3.52e-05	0.000322	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Prednisone—psoriatic arthritis	3.52e-05	0.000322	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Betamethasone—psoriatic arthritis	3.5e-05	0.00032	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Dexamethasone—psoriatic arthritis	3.5e-05	0.00032	CcSEcCtD
Mycophenolate mofetil—Hypotension—Methotrexate—psoriatic arthritis	3.48e-05	0.000318	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	3.39e-05	0.00031	CcSEcCtD
Mycophenolate mofetil—Dizziness—Betamethasone—psoriatic arthritis	3.38e-05	0.000309	CcSEcCtD
Mycophenolate mofetil—Dizziness—Dexamethasone—psoriatic arthritis	3.38e-05	0.000309	CcSEcCtD
Mycophenolate mofetil—Insomnia—Methotrexate—psoriatic arthritis	3.37e-05	0.000308	CcSEcCtD
Mycophenolate mofetil—Nausea—Triamcinolone—psoriatic arthritis	3.35e-05	0.000306	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Methotrexate—psoriatic arthritis	3.35e-05	0.000306	CcSEcCtD
Mycophenolate mofetil—Nausea—Methylprednisolone—psoriatic arthritis	3.34e-05	0.000306	CcSEcCtD
Mycophenolate mofetil—Dyspnoea—Methotrexate—psoriatic arthritis	3.32e-05	0.000304	CcSEcCtD
Mycophenolate mofetil—Somnolence—Methotrexate—psoriatic arthritis	3.31e-05	0.000303	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Prednisone—psoriatic arthritis	3.28e-05	0.0003	CcSEcCtD
Mycophenolate mofetil—Dyspepsia—Methotrexate—psoriatic arthritis	3.28e-05	0.0003	CcSEcCtD
Mycophenolate mofetil—Vomiting—Dexamethasone—psoriatic arthritis	3.25e-05	0.000298	CcSEcCtD
Mycophenolate mofetil—Vomiting—Betamethasone—psoriatic arthritis	3.25e-05	0.000298	CcSEcCtD
Mycophenolate mofetil—Decreased appetite—Methotrexate—psoriatic arthritis	3.24e-05	0.000296	CcSEcCtD
Mycophenolate mofetil—Rash—Dexamethasone—psoriatic arthritis	3.23e-05	0.000295	CcSEcCtD
Mycophenolate mofetil—Rash—Betamethasone—psoriatic arthritis	3.23e-05	0.000295	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Dexamethasone—psoriatic arthritis	3.22e-05	0.000295	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Betamethasone—psoriatic arthritis	3.22e-05	0.000295	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	3.22e-05	0.000294	CcSEcCtD
Mycophenolate mofetil—Headache—Betamethasone—psoriatic arthritis	3.21e-05	0.000293	CcSEcCtD
Mycophenolate mofetil—Headache—Dexamethasone—psoriatic arthritis	3.21e-05	0.000293	CcSEcCtD
Mycophenolate mofetil—Asthenia—Prednisone—psoriatic arthritis	3.2e-05	0.000292	CcSEcCtD
Mycophenolate mofetil—Pain—Methotrexate—psoriatic arthritis	3.19e-05	0.000291	CcSEcCtD
Mycophenolate mofetil—Pruritus—Prednisone—psoriatic arthritis	3.15e-05	0.000288	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Methotrexate—psoriatic arthritis	3.07e-05	0.000281	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Prednisone—psoriatic arthritis	3.05e-05	0.000279	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Methotrexate—psoriatic arthritis	3.05e-05	0.000279	CcSEcCtD
Mycophenolate mofetil—Nausea—Dexamethasone—psoriatic arthritis	3.04e-05	0.000278	CcSEcCtD
Mycophenolate mofetil—Nausea—Betamethasone—psoriatic arthritis	3.04e-05	0.000278	CcSEcCtD
Mycophenolate mofetil—Urticaria—Methotrexate—psoriatic arthritis	2.96e-05	0.000271	CcSEcCtD
Mycophenolate mofetil—Dizziness—Prednisone—psoriatic arthritis	2.95e-05	0.000269	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Methotrexate—psoriatic arthritis	2.94e-05	0.000269	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Methotrexate—psoriatic arthritis	2.94e-05	0.000269	CcSEcCtD
Mycophenolate mofetil—Vomiting—Prednisone—psoriatic arthritis	2.83e-05	0.000259	CcSEcCtD
Mycophenolate mofetil—Rash—Prednisone—psoriatic arthritis	2.81e-05	0.000257	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Prednisone—psoriatic arthritis	2.81e-05	0.000257	CcSEcCtD
Mycophenolate mofetil—Headache—Prednisone—psoriatic arthritis	2.79e-05	0.000255	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Methotrexate—psoriatic arthritis	2.74e-05	0.000251	CcSEcCtD
Mycophenolate mofetil—Asthenia—Methotrexate—psoriatic arthritis	2.67e-05	0.000244	CcSEcCtD
Mycophenolate mofetil—Nausea—Prednisone—psoriatic arthritis	2.65e-05	0.000242	CcSEcCtD
Mycophenolate mofetil—Pruritus—Methotrexate—psoriatic arthritis	2.64e-05	0.000241	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Methotrexate—psoriatic arthritis	2.55e-05	0.000233	CcSEcCtD
Mycophenolate mofetil—Dizziness—Methotrexate—psoriatic arthritis	2.46e-05	0.000225	CcSEcCtD
Mycophenolate mofetil—Vomiting—Methotrexate—psoriatic arthritis	2.37e-05	0.000217	CcSEcCtD
Mycophenolate mofetil—Rash—Methotrexate—psoriatic arthritis	2.35e-05	0.000215	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Methotrexate—psoriatic arthritis	2.35e-05	0.000215	CcSEcCtD
Mycophenolate mofetil—Headache—Methotrexate—psoriatic arthritis	2.33e-05	0.000213	CcSEcCtD
Mycophenolate mofetil—Nausea—Methotrexate—psoriatic arthritis	2.21e-05	0.000202	CcSEcCtD
